Company Overview
- Website
 - cepheid.com
 
- Phone
 - (408) 541-4191
 
- Employees
 - 4,986
 
- Founded in
 - 1996
 
- Industry
 - BioTech/Drugs
 
- Stock Symbol
 - CPHD
 
- NAICS Codes
 - 
                                33 - Manufacturing334 - Computer and Electronic Product Manufacturing3345 - Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451 - Navigational, Measuring, Electromedical, and Control Instruments Manufacturing334516 - Analytical Laboratory Instrument Manufacturing
 
- SIC Codes
 - 
                                38 - Measuring, Analyzing and Controlling Instruments; Photographic, Medical An382 - Laboratory Apparatus and Analytical, Optical, Measuring, and Contr
 
Financials & Stats
Revenue
$587B
Total Funding Amount
$33M
Recent News & Media
How did Edwin Hubble prove Andromeda was a galaxy?
- Jul 7, 2025
 - astronomy.com
 
Cepheid Receives Health Canada Licence for Xpert® HIV-1 Viral Load XC
- Jun 5, 2025
 - biospace.com
 
Cepheid and Oxford Nanopore Technologies partner to advance automated sequencing-based solutions
- May 1, 2025
 - drugdiscoverynews.com
 
Cepheid and Oxford Nanopore Technologies Partner To Advance Automated Sequencing-Based Solutions
- Apr 14, 2025
 - technologynetworks.com
 
Cepheid to lay off 167 people in California
- Apr 14, 2025
 - medtechdive.com
 
Oxford Nanopore inks infectious disease analysis pact with Cepheid
- Apr 10, 2025
 - medicaldevice-network.com
 
Who is Cepheid
Cepheid is a biotechnology company headquartered in Sunnyvale, California. Employing 4,689 individuals, Cepheid generates approximately $587 million in annual revenue. Cepheid specializes in molecular diagnostics, offering GeneXpert® systems and Xpert® tests. These automated solutions streamline complex laboratory procedures, enabling institutions of all sizes to conduct high-quality PCR testing. Their extensive test portfolio covers a wide range of areas, including respiratory infections, blood virology, women's and sexual health, tuberculosis, emerging infectious diseases, healthcare-associated infections, oncology, and human genetics. Cepheid's solutions are designed to deliver timely and actionable results, serving diverse settings such as central laboratories, hospitals, and point-of-care facilities. For further information, please visit Cepheid's website at http://www.cepheid.com.